Source: FDA MedWatch
Overview of the Voluntary Medical Device Correction
Insulet Corporation has initiated a voluntary Medical Device Correction for specific Omnipod 5 Pod lots after detecting a manufacturing issue through routine product monitoring. The action is limited to identified lots distributed in the United States; other Omnipod 5 Pods and all Omnipod products remain safe to use.
The issue concerns a potential small tear in the internal tubing that delivers insulin in certain Pods. If such a tear occurs, insulin may leak inside the Pod rather than being infused into the body as intended, which could result in under-delivery of insulin and elevated blood glucose levels. In the most severe scenarios, persistent high blood glucose can progress to diabetic ketoacidosis (DKA), a condition requiring urgent medical care.
Insulet has received 18 reports describing serious adverse events tied to high blood glucose, including hospitalizations and DKA. Importantly, there have been no reported deaths related to this issue. The company emphasizes that this problem does not affect continuous glucose monitoring (CGM) systems or CGM readings.
In response, Insulet has updated its manufacturing processes and quality controls to strengthen detection and prevention measures, aiming to preserve the integrity of its Omnipod 5 portfolio. The pods implicated in this correction account for approximately 1.5% of global Omnipod 5 production for the year. The company continues to manufacture and ship pods and does not anticipate disruptions to customer shipments, product availability, or new patient starts.
Scope: Affected Pods and Lot Verification
The voluntary correction applies to specific identified lots rather than the entire Omnipod 5 product line. Customers should check their Pod lot numbers through Insulet’s online check-pod tool at omnipod.com/check-pods to determine whether their Pod is part of the recall-like correction and to initiate a replacement pod order at no cost.
If a Pod from an affected lot is currently in use, customers should discontinue use immediately and replace it with a Pod from an unaffected lot. Insulet states that replacement Pods are provided at no charge to eligible customers, and the rest of the Omnipod 5 system remains available for use.
Safety Implications and User Guidance
The central safety concern is under-delivery of insulin caused by a tear in the Pod tubing. Under-delivery can lead to elevated blood glucose levels and, in the worst cases, DKA. This potential risk underlines the need for prompt verification of Pod eligibility and adherence to replacement instructions.
CGM systems and CGM data are unaffected by this correction; users relying on CGMs can continue to use them for glucose monitoring. For pod users who identify as affected, Insulet recommends discontinuing use of the affected Pod and switching to a replacement Pod from an unaffected lot.
For questions or assistance with the replacement process, users may contact Insulet Product Support at 1-800-641-2049 (24/7) or engage with live support via omnipod.com/current-podders.
Manufacturing Improvements and Communications
In addressing the root cause, Insulet has implemented enhancements across its manufacturing line and quality systems to improve detection and prevention of the tubing tear. These adjustments are part of a broader commitment to product integrity and patient safety, with ongoing monitoring to ensure continued reliability of Omnipod 5 Pods and related products.
The FDA has been notified of this voluntary action, underscoring the seriousness with which Insulet treats safety signals. Company leadership emphasizes that patient safety remains the highest priority and that there is no anticipated impact on supply or new patient starts as a result of this correction.
Frequently Asked Questions
What is the scope of the voluntary correction?
The correction covers specific identified lots of Omnipod 5 Pods distributed in the United States, representing roughly 1.5% of annual Omnipod 5 pod production. All other Omnipod 5 Pods and Omnipod products remain safe to use. Replacement Pods are provided at no cost.
How can I verify whether my Pod is affected?
Users should visit omnipod.com/check-pods to check their Pod’s lot number against the list of affected lots. If the Pod is not listed, it is from an unaffected lot and can continue to be used as directed.
What should I do if my Pod is from an affected lot?
If a Pod from an affected lot is currently in use, discontinue use immediately and replace it with a Pod from an unaffected lot. Contact Insulet Product Support for guidance and arrange for a replacement Pod at no cost.
Will this affect Omnipod 5 shipments or new patient starts?
No. Insulet continues to manufacture and ship Omnipod 5 Pods, and the company does not anticipate disruptions to product availability or new patient starts. The affected portion represents about 1.5% of annual production.